|Articles|November 1, 2012
- BioPharm International-11-01-2012
- Volume 25
- Issue 11
BioPharm International, November 2012 Issue (PDF)
Biosimilars : New Guidelines Set for Monoclonal Antibodies
Advertisement
Articles in this issue
about 13 years ago
The Transformation to Process-Centered Organizationabout 13 years ago
Considerations for Scale-Up of Stem-Cell Culturesabout 13 years ago
Creating a Holistic Procurement Systemabout 13 years ago
Product Characterization: A Primerabout 13 years ago
A 25-Year Retrospective on Protein Recovery through Membrane Filtersabout 13 years ago
Assay Development and Method Validation Essentialsabout 13 years ago
Discovery Pipeline: Improved Delivery of RNA Vaccinesabout 13 years ago
How to Manage Effective Leadership when Change is the Only Constantabout 13 years ago
Product Analysis Key to Biosimilar DevelopmentNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
3
How Mitigation and Maintenance Protect Against Future Risk
4
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
5
